Article
CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas
1 Jan 2012
Abstract excerpt
CD24 is overexpressed in glioma cells in vitro and in vivo. However, the correlation of its expression with clinicopathological parameters of gliomas and its prognostic significance in this tumor remain largely unknown. To address this problem, 151 glioma specimens and 10 nonneoplastic brain tissues were collected. Quantitative real-time PCR, immunochemistry assay, and Western blot analysis were carried out to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
